About Anders

Anders Tullgren is a global leader, strategist, and consultant with over 30 years of experience in the life sciences field. His vision and leadership have changed the game for diverse organisations—from multibillion-dollar big pharma to emerging biotech, pharma, and e-healthcare companies.

After building a successful career as a bold and strategic executive for Bristol-Myers Squibb (BMS), Anders set his sights on small- and mid-sized businesses. He created Tullgren Consulting Ltd. from its inception to provide customised consulting and advisory services for pharma/biotech companies, private equity firms, and investment banks based in the United States and Europe.

His commitment to the future of healthcare has inspired Anders to become board member and chairperson of several public and private companies. He is currently chairperson of Xbrane Biopharma AB (Sweden), and serves on the boards of Farmalisto (Panama), Branding Science Ltd. (UK), and Dizlin Pharmaceuticals AB (Sweden). In the past, he was board chair of Trialbee AB (Sweden), and held directorships with Symphogen AS (Denmark) and Biotoscana (Luxembourg).

As Founder and Principal Consultant with Tullgren Consulting, Anders drives transformation and growth through client-focused engagements—adding value every step of the way. He reshapes strategy, revamps commercial and operational structures, turns around underperformance, launches products, opens international markets, drives revenue, cuts costs, and negotiates